Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex difference

Archive ouverte

Garreau, Romain | Bricca, Romain | Gagnieu, Marie-Claude | Roux, Sandrine | Conrad, Anne | Bourguignon, Laurent | Ferry, Tristan | Goutelle, Sylvain | Valour, Florent | Perpoint, Thomas | Miailhes, Patrick | Ader, Florence | Becker, Agathe | Triffault-Fillit, Claire | Pouderoux, Cécile | Benech, Nicolas | Chauvelot, Pierre | Perry, Marielle | Daoud, Fatiha | Lippman, Johanna | Braun, Evelyne | Chidiac, Christian | Servien, Elvire | Lustig, Sébastien | Batailler, Cécile | Gunst, Stanislas | Schmidt, Axel | Malatray, Matthieu | Sappey-Marinier, Elliot | Fessy, Michel-Henry | Viste, Anthony | Besse, Jean-Luc | Chaudier, Philippe | Louboutin, Lucie | Ode, Quentin | van Haecke, Adrien | Mercier, Marcelle | Belgaid, Vincent | Walch, Arnaud | Martres, Sébastien | Trouillet, Franck | Barrey, Cédric | Mojallal, Ali | Brosset, Sophie | Hanriat, Camille | Person, Hélène | Sigaux, Nicolas | Céruse, Philippe | Fuchsmann, Carine | Aubrun, Frédéric | Dziadzko, Mikhail | Macabéo, Caroline | Laurent, Frederic | Beraud, Laetitia | Roussel-Gaillard, Tiphaine | Dupieux, Céline | Kolenda, Camille | Josse, Jérôme | Brevet, Marie | Trecourt, Alexis | Craighero, Fabien | Boussel, Loic | Pialat, Jean-Baptiste | Morelec, Isabelle | Tod, Michel | Mabrut, Eugénie

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Background Daptomycin is increasingly used in the treatment of bone and joint infection (BJI), but its pharmacokinetics (PK) and dosage requirements have not been thoroughly investigated in this indication. Daptomycin may be co-administered with rifampicin, which raises questions about a potential drug interaction. Objectives To investigate the population PK and dosage requirements of daptomycin in patients with BJI, and examine the influence of rifampicin co-administration. Methods A population approach was used to analyse PK data from patients who received daptomycin in our regional reference for BJI. We examined the influence of available covariates, including rifampicin co-administration on daptomycin PK. Simulations performed with the final model investigated the influence of dosages and covariates on PTA for both efficacy and safety. Results A total of 1303 daptomycin concentrations from 183 patients were analysed. A two-compartment model best described the data. Significant intra-individual variability was observed. Daptomycin clearance was influenced by renal function and sex, with females having a 26% lower typical clearance than males. Central volume of distribution (V1) was influenced by body weight, age, sex and rifampicin co-administration. Typical V1 was 11% lower in patients who were co-administered rifampicin. In PK/PD simulations, sex influenced the probability of AUC24/MIC target attainment, while rifampicin had a marginal effect. Conclusions A daptomycin dosage of 8 mg/kg/24 h in women and 10 mg/kg/24 h in men should optimize efficacy but may lead to excessive trough concentrations in many patients, especially in women. Therapeutic drug monitoring appears necessary for precision dosing of daptomycin.

Consulter en ligne

Suggestions

Du même auteur

Coxiella burnetti prosthetic joint infection in an immunocompromised woman: iterative surgeries, prolonged ofloxacin-rifampin treatment and complex reconstruction were needed for the cure

Archive ouverte | Miailhes, Patrick | CCSD

International audience. Abstract Background Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii , a strictly intracellular pathogen that can cause acute and chronic infection. Chronic Q fever can...

Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years' experience

Archive ouverte | Ferry, Tristan | CCSD

International audience

Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection

Archive ouverte | Chauvelot, Pierre | CCSD

International audience. Abstract Objectives Long-acting lipoglycopeptides are promising therapeutic options in Staphylococcus aureus bone and joint infections (BJIs). This study evaluated the ability of dalbavancin ...

Chargement des enrichissements...